Abstract
This paper addresses the challenge of identifying causal effects in randomized controlled trials (RCTs) characterized by noncompliance. Traditionally, point identification in these settings requires restrictive assumptions like monotonicity. We propose a novel identification condition that leverages an instrumental variable (IV) and a proxy variable of potential outcomes. By demonstrating that the joint probabilities of potential outcomes can be uniquely determined through matrix inversion of observed data, this method allows for consistent estimation of causal effects without relying on monotonicity, independence between potential outcomes, or gain equality assumptions.
Introduction
In randomized trials, noncompliance occurs when participants do not adhere to their assigned treatment groups. While Intention-to-Treat (ITT) analysis provides a valid estimate of the effect of assignment, it often fails to capture the true effect of the treatment itself. Instrumental Variable (IV) methods are typically employed to address this, but they generally only provide bounds for the causal effect unless strong assumptions, such as monotonicity (the assumption that no one does the opposite of their assignment), are invoked. However, monotonicity is often violated in real-world social and medical contexts. This research explores whether additional covariate information, specifically a proxy variable, can achieve point identification without such constraints.
The Proxy Variable Framework
The proposed methodology introduces a proxy variable, $W$, which serves as a noisy measurement of the latent factors $U$ that influence both treatment selection ($X$) and the final outcome ($Y$).
As shown in the causal diagrams above, the framework assumes that the instrumental variable $Z$ affects the outcome $Y$ only through the treatment $X$. The key innovation is the inclusion of $W$, which is conditionally independent of $Z$ given the latent response types. These response types categorize individuals into four groups: those who always get the disease ("Doomed"), those who only get it if treated ("Causative"), those who only get it if untreated ("Preventive"), and those who never get it ("Immune").
Identification via Matrix Inversion
The core technical contribution is Theorem 1, which establishes the conditions for point identification. The author constructs matrices ($P_x$ and $Q_x$) based on the observed joint probabilities of $(Z, X, Y, W)$.
If the proxy variable $W$ has at least four categories (corresponding to the four potential outcome types) and the relationship between $W$ and the latent types is sufficiently strong to ensure matrix invertibility, the joint probabilities of the potential outcomes can be uniquely solved. This approach is particularly powerful because the invertibility of these matrices is a testable condition using observed data, providing researchers with a way to verify the validity of their proxy variable.
Conclusion and Implications
By moving beyond the monotonicity assumption, this work significantly expands the toolkit for causal inference in the presence of noncompliance. The ability to calculate the "probability of necessity and sufficiency" has profound implications for personalized medicine and legal reasoning, where understanding individual-level response types is critical.
While the current framework focuses on binary treatments and outcomes, it provides a robust foundation for future extensions to multi-categorical variables. The primary practical challenge remains the selection of an appropriate proxy variable $W$ that is sufficiently informative of the latent response types without being directly influenced by the instrument $Z$.
Summary updated